- Report
- February 2024
- 70 Pages
India
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 90 Pages
Asia Pacific
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 100 Pages
Asia Pacific
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 80 Pages
Europe
From €4206EUR$4,750USD£3,604GBP
- Report
- February 2024
- 70 Pages
New Zealand
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2023
- 110 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2023
- 90 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2023
- 80 Pages
Africa, Middle East
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2023
- 75 Pages
North America
From €4206EUR$4,750USD£3,604GBP
- Report
- October 2022
- 70 Pages
Africa
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2025
- 200 Pages
India
From €2470EUR$2,789USD£2,116GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,116GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2470EUR$2,789USD£2,116GBP
- Report
- June 2025
- 400 Pages
Global
From €4383EUR$4,949USD£3,755GBP
- Report
- August 2024
- 150 Pages
Global
From €2470EUR$2,789USD£2,116GBP
- Report
- February 2024
- 80 Pages
Latin America
From €4206EUR$4,750USD£3,604GBP
- Report
- March 2026
- 136 Pages
France
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP
- Report
- May 2024
- 139 Pages
Global
From €2656EUR$2,999USD£2,275GBP
€3541EUR$3,999USD£3,034GBP

Metformin is a drug used to treat endocrine and metabolic disorders, such as type 2 diabetes. It is a biguanide, a class of drugs that work by decreasing the amount of glucose produced by the liver and increasing the body's sensitivity to insulin. Metformin is the most commonly prescribed drug for type 2 diabetes, and is also used to treat polycystic ovary syndrome and gestational diabetes. It is generally well-tolerated, with few side effects.
The Metformin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Teva Pharmaceuticals, Mylan, Sandoz, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin, and Aurobindo Pharma. Show Less Read more